Veysel Suzan

Veysel Suzan

Auto-generated profile, based on publicly available information

Veysel Suzan

İstanbul Eğitim ve Araştırma Hastanesi

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2020 in European Geriatric Medicine
Verified
Journal Article
Closed access
PDF file
VSVeysel Suzan
Veysel Suzan
ASAysegul Akkan Suzan
Aysegul Akkan Suzan

14 September 2020 in International Journal of Fuzzy Systems
Verified
Journal Article
Closed access
PDF file
VSVeysel Suzan
Veysel Suzan
HYHakan Yavuzer
Hakan Yavuzer

28 October 2022 in Psychogeriatrics
Verified
Journal Article
Closed access
GAGulru Ulugerger Avci
Gulru Ulugerger Avci
VSVeysel Suzan
Veysel Suzan
BKBahar Bektan Kanat
Bahar Bektan Kanat
DUDamla Unal
Damla Unal
TGTugce Emiroglu Gedik
Tugce Emiroglu Gedik
HYHakan Yavuzer
Hakan Yavuzer

19 May 2023 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
GAGulru Ulugerger Avci
Gulru Ulugerger Avci
BKBahar Bektan Kanat
Bahar Bektan Kanat
GCGünay Can
Günay Can
VSVeysel Suzan
Veysel Suzan
DUDamla Unal
Damla Unal
ADAlper Doventas
Alper Doventas

1 November 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
VSVeysel Suzan
Veysel Suzan
BKBahar Bektan Kanat
Bahar Bektan Kanat
HYHakan Yavuzer
Hakan Yavuzer
This study aimed to investigate the frequency of fatigue in geriatric patients with primary sarcopenia and to evaluate the relationship between fatigue and symptoms such as depression and sleepiness. This case-control study was conducted between December 2020 and August 2021 in the geriatrics outpatient clinic of Istanbul University-Cerrahpasa. The European Working Group on Sarcopenia in Older People 2 criteria were considered for the diagnosis of sarcopenia. Demographic data, accompanying chronic diseases, comprehensive geriatric assessments, and laboratory values of the patients were noted. Scales used to assess fatigue in all participants include Fatigue Assessment Scale, Fatigue Severity Scale, and Fatigue Impact Scale and associated symptoms include Geriatric Depression Scale and Epworth Sleepiness Scale. The mean (standard deviation) age was 75.3 (7.1) for 51 primary sarcopenia (38 female) patients and 73.5 (5.8) for 51 control (37 female) patients. There was no significant difference between the two groups in terms of gender and age (p=0.822, p=0.171). The prevalence of hypertension was higher, and the level of education was lower in the sarcopenic group than in the nonsarcopenic group (p=0.017, p=0.013). Fatigue Assessment Scale, Fatigue Severity Scale, Fatigue Impact Scale total, Fatigue Impact Scale cognitive, Fatigue Impact Scale physical, and Fatigue Impact Scale social questionnaire scores were significantly higher in the sarcopenic group (all p<0.001). The Geriatric Depression Scale score was statistically higher in the sarcopenic group; however, there was no significant difference in the Epworth Sleepiness Scale score between the two groups (p=0.014, p=0.072). Multivariate analysis was performed on education level, hypertension, fatigue questionnaires, and Geriatric Depression Scale, which were found to be significant in the univariate logistic regression analysis. In the multivariate logistic regression analysis, only the Fatigue Impact Scale total was determined to be associated with sarcopenia [odds ratio 1.161, 95% confidence interval (1.084–1.242)]. In primary sarcopenia, there is mental and social fatigue as well as physical fatigue. Therefore, the prevention and treatment of sarcopenia in geriatric patients is important.

30 April 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
RSRabia Bag Soytas
Rabia Bag Soytas
MEMurat Esmer
Murat Esmer
PAPınar Arman
Pınar Arman
VSVeysel Suzan
Veysel Suzan
TGTuğçe EMİROĞLU GEDİK
Tuğçe EMİROĞLU GEDİK
ADAlper Doventas
Alper Doventas
Background/aim: We aimed to investigate the factors affecting the mortality of patients aged 65 years or older who were hospitalized with the diagnosis of new coronavirus pneumonia (COVID-19). Materials and methods: This is a retrospective study of patients 65 years old or older with COVID-19 who were hospitalized in Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty Hospital, between March 11 and May 28, 2020. Demographic, clinical, treatment, and laboratory data were extracted from electronic medical records. We used univariate and multivariate logistic regression methods to explore the risk factors for in-hospital death. Results: A total of 218 patients (112 men, 106 women) were included, of whom 166 were discharged and 52 died in hospital. With univariate analysis, various clinical features and laboratory variables were found to be significantly different (i.e. P < 0.05). In multivariate logistic regression analysis the following were independently associated with mortality: present malignancy [odds ratio (OR) = 4.817, 95% confidence interval (CI) = 1.107-20.958, P: 0.036]; dyspnea (OR = 4.652, 95% CI = 1.473-14.688, P: 0.009); neutrophil/lymphocyte ratio (NLR; OR = 1.097, 95% CI = 1.012-1.188, P: 0.025); the highest values of C-reactive protein (CRP; OR = 1.006, 95% CI = 1.000-1.012, P: 0.049), lactate dehydrogenase (LDH; OR = 1.002, 95% CI = 1.001-1.004, P: 0.003), and creatinine levels (OR = 1.497, 95% CI = 1.126-1.990, P: 0.006); oxygen saturation (SpO2) values on admission (OR = 0.897, 95% CI = 0.811-0.993, P: 0.036); and azithromycin use (OR = 0.239, 95% CI = 0.065-0.874, P: 0.031). Conclusion: The presence of malignancy; symptoms of dyspnea; high NLR; highest CRP, LDH, and creatinine levels; and low SpO2 on admission predicted mortality. On the other hand, azithromycin use was found to be protective against mortality. Knowing the causes predicting mortality will be important to treat future cases more successfully.